Randomised Phase II trial of irinotecan with hyaluronic acid (HyCAMP) versus irinotecan as treatment for patients with metastatic colorectal cancer who have failed 5-FU based chemotherapy (CTA 2004) ............incidence of grade 3 or 4 diarrhoea.
100 Clinical Results associated with Meditech Research Ltd.
0 Patents (Medical) associated with Meditech Research Ltd.
100 Deals associated with Meditech Research Ltd.
100 Translational Medicine associated with Meditech Research Ltd.